| # | Drug | Count |
|---|---|---|
| 0 | INFLIXIMAB | 12 |
| 1 | METHOTREXATE | 12 |
| 2 | METHOTREXATE SODIUM | 12 |
| 3 | ADALIMUMAB | 10 |
| 4 | IBUPFROFEN | 8 |
| 5 | IBUPROFEN | 8 |
| 6 | IBUPROFEN 200 MG | 8 |
| 7 | IBUPROFEN 200MG | 8 |
| 8 | IBUPROFEN CAPSULE | 8 |
| 9 | IBUPROFEN CAPSULES 200 MG | 8 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | ESTRONE | 1 | 0.0093 |
| 1 | CHLORHEXIDINE GLUCONATE AND ISOPROPYL ALCOHOL | 1 | 0.0033 |
| 2 | DOSTARLIMAB | 2 | 0.0008 |
| 3 | ATROPINE INJECTION, 2 MG | 1 | 0.0007 |
| 4 | DESOGESTREL AND ETHINYL ESTRADIOL | 2 | 0.0006 |
| 5 | GOLIMUMAB | 7 | 0.0006 |
| 6 | SOLIFENACIN SUCCIATE | 1 | 0.0005 |
| 7 | ALENDRONATE SODIUM AND CHOLECALCIFEROL | 1 | 0.0004 |
| 8 | OXYTOCIN | 1 | 0.0003 |
| 9 | ERGOCALCIFEROL | 7 | 0.0002 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Oxytocic [EPC] | 1 | 0.0003 |
| 1 | Provitamin D2 Compound [EPC] | 7 | 0.0002 |
| 2 | Chloride Channel Activator [EPC] | 2 | 0.0002 |
| 3 | Calcitonin Gene-related Peptide Receptor Antagonist [EPC] | 1 | 0.0001 |
| 4 | Copper-containing Intrauterine Device [EPC] | 7 | 0.0001 |
| 5 | Substance P/Neurokinin-1 Receptor Antagonist [EPC] | 1 | 0.0001 |
| 6 | Calcitonin Gene-related Peptide Antagonist [EPC] | 1 | 0.0001 |
| 7 | Melatonin Receptor Agonist [EPC] | 1 | 0.0001 |
| 8 | Histamine-1 Receptor Antagonist [EPC] | 6 | 0.0001 |
| 9 | Interleukin-23 Antagonist [EPC] | 7 | 0.0001 |